Georgetown University: Breast Neoplasms trials

The registry lists 33 Breast Neoplasms studies with Georgetown University as lead sponsor. 3 are open to participants now and 13 have results posted.

Phase 1 4Phase 2 13Phase 3 2Phase 4 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and TestingRecruitingNCT05130606Not applicable
• Genetic Education in BRCA FamiliesEnrolling by invitationNCT03544983Not applicable
• Older Breast Cancer Patients: Risk for Cognitive DeclineRecruitingNCT03451383
• Oral SM-88 in Patients With Metastatic HR+/HER2- Breast CancerTerminatedNCT04720664Phase 2Results posted
• Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based CohortsTerminatedNCT04657679Phase 4Results posted
• Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for SurgeryTerminatedNCT03535506Phase 2Results posted
• OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual DiseaseCompletedNCT03487666Phase 2Results posted
• ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2CompletedNCT03029286Not applicableResults posted
• Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast CancerCompletedNCT02692755Phase 2/3Results posted
• CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)TerminatedNCT02365714Phase 1/2Results posted
• Nueva Vida Intervention for Latina Breast Cancer Survivors and CaregiversCompletedNCT02222337Not applicableResults posted
• Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast CancerTerminatedNCT01484041Phase 1/2Results posted
• Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the BreastTerminatedNCT00898937Results posted
• Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine TherapyTerminatedNCT00661531Phase 2Results posted
• Genetic Testing in Predicting Response to Paclitaxel in Women With Breast CancerTerminatedNCT00088829Phase 2Results posted
• Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast CancerCompletedNCT00073073Phase 2Results posted
• TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast CancerActive, not recruitingNCT03964532Phase 1/2
• Testing a Culturally Adapted Telephone Genetic Counseling InterventionCompletedNCT03959267Not applicable
• WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 InhibitorCompletedNCT03854903Phase 1
• Web-Based Communication Education for Breast Cancer Survivorship CareStatus unknownNCT03413332Not applicable
• Acupressure for Cancer-Related FatigueStatus unknownNCT03091647Not applicable
• Predictors of Adjuvant Endocrine Therapy in Women With Breast CancerStatus unknownNCT02992730
• The Genetic Education for Men Trial: Web-Based Education vs. Standard CareCompletedNCT02957981Not applicable
• Exergaming Intervention and Breast Cancer Biomarkers in Black WomenCompletedNCT02152462Phase 2
• Effects of a Structured Exercise Program on Cancer-Related Fatigue in Women Receiving Radiation Therapy for Breast CancerCompletedNCT02117011Not applicable
• Breast Health in Chinese American WomenCompletedNCT01292200Not applicable
• Registry of Mastectomy for Breast Cancer Risk ReductionCompletedNCT00555503
• A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial BreastWithdrawnNCT00529334Not applicable
• Genetic Counseling in Women at Risk for BRCA1 or BRCA2 MutationsCompletedNCT00416754Not applicable
• Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 MutationCompletedNCT00287898Not applicable
• Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment DecisionsCompletedNCT00262899Phase 3
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsCompletedNCT00003125Phase 2
• Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast CancerCompletedNCT00003035Phase 2